Controlling Recombination to Evolve Bacteriophages

James J. Bull,Holly A. Wichman,Stephen M. Krone,Ian J. Molineux

DOI: https://doi.org/10.3390/cells13070585

IF: 6

2024-03-29

Cells

Abstract:Recombination among different phages sometimes facilitates their ability to grow on new hosts. Protocols to direct the evolution of phage host range, as might be used in the application of phage therapy, would then benefit from including steps to enable recombination. Applying mathematical and computational models, in addition to experiments using phages T3 and T7, we consider ways that a protocol may influence recombination levels. We first address coinfection, which is the first step to enabling recombination. The multiplicity of infection (MOI, the ratio of phage to cell concentration) is insufficient for predicting (co)infection levels. The force of infection (the rate at which cells are infected), is also critical but is more challenging to measure. Using both a high force of infection and high MOI (>1) for the different phages ensures high levels of coinfection. We apply a four-genetic-locus model to study protocol effects on recombinant levels. Recombinants accumulate over multiple generations of phage growth, less so if one phage outgrows the other. Supplementing the phage pool with the low-fitness phage recovers some of this 'lost' recombination. Overall, fine tuning of phage recombination rates will not be practical with wild phages, but qualitative enhancement can be attained with some basic procedures.

cell biology

What problem does this paper attempt to address?

This paper attempts to address the issue of how to evolve bacteriophages to infect new hosts by controlling recombination in phage therapy. Specifically, the paper explores the following points:

1. **Background Issues**:
- One advantage of phage therapy is its specificity, meaning each phage can only infect specific host bacteria, which reduces disruption to the microbial community.
- However, this specificity also presents a problem, as finding phages that can target specific bacteria in a patient's body becomes difficult.
- Additionally, during treatment, bacteria may quickly evolve resistance to the phages, rendering the therapy ineffective.

2. **Solution**:
- The paper proposes a potential solution: evolving phages to have new host ranges through "directed evolution."
- Directed evolution typically involves exposing phages to the desired bacterial targets, and recombination can significantly accelerate the phages' adaptation to new hosts in this process.

3. **Research Methods**:
- Using mathematical models and computational simulations to study the levels of phage coinfection under different experimental conditions.
- Special attention is given to the relationship between the multiplicity of infection (MOI) and the force of infection.
- It was found that MOI alone is insufficient to predict coinfection levels; the force of infection is equally important but more challenging to measure.

4. **Key Findings**:
- High force of infection and high MOI (>1) ensure high levels of coinfection.
- Coinfection accumulates over multiple generations of phage growth, but if one phage overgrows, it reduces recombination.
- Supplementing the phage pool with low-fitness phages can partially restore "lost" recombination.
- For wild-type phages, precisely controlling recombination rates is impractical, but qualitative enhancement can be achieved through some basic procedures.

In summary, this paper aims to explore how controlling coinfection can increase phage recombination levels, thereby better adapting them to new host bacteria and improving the effectiveness of phage therapy.